American Samoa vs Turks and Caicos Islands: Tuberculosis treatment success rate
American Samoa
100.0%
in 2019
Turks and Caicos Islands
100.0%
in 2018
American Samoa rank
1st
Turks and Caicos Islands rank
1st
Tuberculosis treatment success rate over time
- American Samoa
- Turks and Caicos Islands
How they compare
American Samoa currently reports 100.0% against 100.0% in Turks and Caicos Islands, a difference of 0.0%.
The two have swapped places 2 times across 7 shared years of data; in 1998 it was Turks and Caicos Islands ahead.
American Samoa ranks 1st and Turks and Caicos Islands ranks 1st of 206 countries.
Across the 3 decades both report, American Samoa averaged higher in 2 and Turks and Caicos Islands in 1.
Head to head by decade
| Decade | American Samoa | Turks and Caicos Islands | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 50.0% | 71.0% | 21.0% | Turks and Caicos Islands |
| 2000s | 91.7% | 22.3% | 69.3% | American Samoa |
| 2010s | 93.3% | 78.3% | 15.0% | American Samoa |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis treatment success rate, American Samoa or Turks and Caicos Islands?
- American Samoa, at 100.0% against 100.0% in Turks and Caicos Islands as of 2019.
- What is the difference in tuberculosis treatment success rate between American Samoa and Turks and Caicos Islands?
- 0.0%, with American Samoa ahead.
- How many years of comparable data are there for American Samoa and Turks and Caicos Islands?
- 7 years are reported by both, from 1998 to 2018.
- How do American Samoa and Turks and Caicos Islands rank globally for tuberculosis treatment success rate?
- American Samoa ranks 1st and Turks and Caicos Islands ranks 1st of 206 countries.
- Where does this data come from?
- WHO (2025) – with minor processing by Our World in Data, published as Tuberculosis treatment success rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Treatment success rate among new and relapse cases.